AKR1B10 and hepatocellular carcinoma: In HCC cells, inhibition of AKR1B10 expression resulted in cell cycle arrest and impaired cell proliferation, suggesting that AKR1B10 may exert tumorigenic effects through enhanced cell growth [35].